ERBB2 and breast cancer: To test the actual roles of autophagy, we treated both HER2-positive breast cancer cells with T-DM1 and CQ, which was a typical inhibitor that inhibited the integrating of lysosomes and autophagosomes and blocked autophagosome formation.